• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛患者的尿液药物检测:合法与非法药物模式

Urine drug testing of chronic pain patients: licit and illicit drug patterns.

作者信息

Cone Edward J, Caplan Yale H, Black David L, Robert Timothy, Moser Frank

机构信息

Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

出版信息

J Anal Toxicol. 2008 Oct;32(8):530-43. doi: 10.1093/jat/32.8.530.

DOI:10.1093/jat/32.8.530
PMID:19007501
Abstract

Chronic pain patients are frequently maintained on one or more powerful opioid medications in combination with other psychoactive medications. Urine tests provide objective information regarding patient compliance status. Little information is available on testing this unique population. The goal of this study was to characterize drug disposition patterns in urine specimens collected from a large population of pain patients. Confirmation data for 10,922 positive specimens were collated into 11 drug Classes. The number of drug/metabolites tested (#) and number of confirmed positive specimens were as follows: amphetamines (7), 160; barbiturates (5), 308; benzodiazepines (6), 2397; cannabinoids (1), 967; carisoprodol (2), 611; cocaine (1), 310; fentanyl (1), 458; meperidine (2), 58; methadone (2), 1209; opiates (7), 8996; and propoxyphene (2), 385. Subdivision into 19 distinct drug Groups allowed characterization of drug use patterns. Of the 10,922 positive specimens, 15,859 results were reported as positive in various drug Classes, and 27,197 drug/metabolites were measured by gas chromatography-mass spectrometry. The frequency of illicit drug use (cannabis, cocaine, ecstasy) was 10.8%. Being the first study of this type, these data present a large array of information on licit and illicit drug use, drug detection frequencies, drug/metabolite patterns, and multi-drug use combinations in pain patients.

摘要

慢性疼痛患者经常同时服用一种或多种强效阿片类药物以及其他精神活性药物。尿液检测可提供有关患者依从性状况的客观信息。关于检测这一特殊人群的信息很少。本研究的目的是描述从大量疼痛患者收集的尿液标本中的药物处置模式。10922份阳性标本的确认数据被整理为11类药物。检测的药物/代谢物数量(#)和确认的阳性标本数量如下:苯丙胺类(7种),160例;巴比妥类(5种),308例;苯二氮䓬类(6种),2397例;大麻素类(1种),967例;卡立普多(2种),611例;可卡因(1种),310例;芬太尼(1种),458例;哌替啶(2种),58例;美沙酮(2种),1209例;阿片类(7种),8996例;丙氧芬(2种),385例。细分为19个不同的药物组有助于描述药物使用模式。在10922份阳性标本中,15859份结果在各类药物中报告为阳性,通过气相色谱-质谱法检测了27197种药物/代谢物。非法药物使用(大麻、可卡因、摇头丸)的频率为10.8%。作为此类的第一项研究,这些数据提供了大量关于疼痛患者合法和非法药物使用、药物检测频率、药物/代谢物模式以及多药使用组合的信息。

相似文献

1
Urine drug testing of chronic pain patients: licit and illicit drug patterns.慢性疼痛患者的尿液药物检测:合法与非法药物模式
J Anal Toxicol. 2008 Oct;32(8):530-43. doi: 10.1093/jat/32.8.530.
2
Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.慢性疼痛患者的口腔液药物检测。一、合法和非法药物的阳性检出率。
J Anal Toxicol. 2011 Oct;35(8):529-40. doi: 10.1093/anatox/35.8.529.
3
Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).法国北部加来海峡地区卡车司机中精神活性物质的流行情况。
Forensic Sci Int. 2008 Jan 30;174(2-3):90-4. doi: 10.1016/j.forsciint.2007.03.004. Epub 2007 Apr 6.
4
Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.口腔液中滥用药物和阿片类治疗药物的流行情况及处置
J Anal Toxicol. 2007 Oct;31(8):424-33. doi: 10.1093/jat/31.8.424.
5
Predictive Value of Positive Drug Screening Results in an Urban Outpatient Population.城市门诊人群药物筛查阳性结果的预测价值
J Anal Toxicol. 2016 Nov;40(9):726-731. doi: 10.1093/jat/bkw088. Epub 2016 Aug 22.
6
Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines.LUCIO®-direct ELISA 与 CEDIA 免疫分析法在德国重新许可准则要求的尿液“零容忍”药物筛选中的比较。
Drug Test Anal. 2013 Jun;5(6):390-9. doi: 10.1002/dta.1455. Epub 2013 Jan 24.
7
Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches.使用多瑞吉透皮贴剂期间尿液中芬太尼和去甲芬太尼的浓度。
J Anal Toxicol. 2004 Sep;28(6):422-5. doi: 10.1093/jat/28.6.422.
8
Validity of self-reported drug use in chronic pain patients.慢性疼痛患者自我报告药物使用情况的有效性。
Clin J Pain. 1999 Sep;15(3):184-91. doi: 10.1097/00002508-199909000-00005.
9
Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS.采用液相色谱-串联质谱法同时测定尿液中多种滥用药物及相关代谢物。
J Anal Toxicol. 2007 Sep;31(7):359-68. doi: 10.1093/jat/31.7.359.
10
Patterns of drug use by participants in the Western Australian methadone program, 1984-1991.1984 - 1991年西澳大利亚美沙酮项目参与者的药物使用模式
Med J Aust. 1993 Sep 20;159(6):373-6. doi: 10.5694/j.1326-5377.1993.tb137908.x.

引用本文的文献

1
A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing.临床实验室面临的一项艰巨挑战:获取并解读尿液药物检测中免疫分析所使用的制造商交叉反应性数据。
Acad Pathol. 2018 Nov 21;5:2374289518811797. doi: 10.1177/2374289518811797. eCollection 2018 Jan-Dec.
2
Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States.美国一个为期6个月的疼痛管理样本中的大麻使用模式。
Subst Abuse. 2017 Aug 16;11:1178221817724783. doi: 10.1177/1178221817724783. eCollection 2017.
3
Illicit Substance Use in US Adults With Chronic Low Back Pain.
美国慢性下腰痛成年人中的非法药物使用情况。
Spine (Phila Pa 1976). 2016 Sep;41(17):1372-1377. doi: 10.1097/BRS.0000000000001702.
4
The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain.在接受阿片类药物治疗慢性疼痛的初级保健患者中,苯二氮䓬类药物处方与异常药物相关行为之间的关联。
Subst Abus. 2016 Oct-Dec;37(4):516-520. doi: 10.1080/08897077.2016.1179242. Epub 2016 Apr 19.
5
Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects.临床疼痛患者与疼痛研究受试者的尿液药物检测概况。
Pain Med. 2016 Apr;17(4):636-43. doi: 10.1111/pme.12900. Epub 2016 Jan 28.
6
Current knowledge on cannabinoids in oral fluid.关于口腔液中大麻素的现有知识。
Drug Test Anal. 2014 Jan-Feb;6(1-2):88-111. doi: 10.1002/dta.1514. Epub 2013 Aug 25.
7
Prescription opioid abuse: challenges and opportunities for payers.处方阿片类药物滥用:支付方面临的挑战与机遇。
Am J Manag Care. 2013 Apr;19(4):295-302.
8
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?口服液大麻素检测能否监测口服 THC 和口腔黏膜用 Sativex 给药期间的药物依从性和/或大麻吸烟情况?
Drug Alcohol Depend. 2013 Jun 1;130(1-3):68-76. doi: 10.1016/j.drugalcdep.2012.10.011. Epub 2012 Nov 10.